Figure S2 from CD103&lt;sup&gt;+&lt;/sup&gt; Tumor-Resident CD8&lt;sup&gt;+&lt;/sup&gt; T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment